{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,16]],"date-time":"2026-04-16T09:40:00Z","timestamp":1776332400937,"version":"3.50.1"},"reference-count":39,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,11,1]],"date-time":"2022-11-01T00:00:00Z","timestamp":1667260800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,11,1]],"date-time":"2022-11-01T00:00:00Z","timestamp":1667260800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,10,9]],"date-time":"2023-10-09T00:00:00Z","timestamp":1696809600000},"content-version":"am","delay-in-days":342,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,11,1]],"date-time":"2022-11-01T00:00:00Z","timestamp":1667260800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,11,1]],"date-time":"2022-11-01T00:00:00Z","timestamp":1667260800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,11,1]],"date-time":"2022-11-01T00:00:00Z","timestamp":1667260800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,11,1]],"date-time":"2022-11-01T00:00:00Z","timestamp":1667260800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,11,1]],"date-time":"2022-11-01T00:00:00Z","timestamp":1667260800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R01 AR063795"],"award-info":[{"award-number":["R01 AR063795"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002428","name":"Austrian Science Fund","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002428","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Bioorganic &amp; Medicinal Chemistry Letters"],"published-print":{"date-parts":[[2022,11]]},"DOI":"10.1016\/j.bmcl.2022.129014","type":"journal-article","created":{"date-parts":[[2022,10,3]],"date-time":"2022-10-03T22:20:32Z","timestamp":1664835632000},"page":"129014","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":10,"special_numbering":"C","title":["Development of a putative Zn2+-chelating but highly selective MMP-13 inhibitor"],"prefix":"10.1016","volume":"76","author":[{"given":"Rita","family":"Fuerst","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jun Yong","family":"Choi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anna M.","family":"Knapinska","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael D.","family":"Cameron","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Claudia","family":"Ruiz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Amber","family":"Delmas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mark S.","family":"Sundrud","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gregg B.","family":"Fields","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"William R.","family":"Roush","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.bmcl.2022.129014_h0005","doi-asserted-by":"crossref","first-page":"14194","DOI":"10.1074\/jbc.M313474200","article-title":"Similarity of binding sites of human matrix metalloproteinases","volume":"279","author":"Lukacova","year":"2004","journal-title":"J Biol Chem"},{"key":"10.1016\/j.bmcl.2022.129014_h0010","doi-asserted-by":"crossref","first-page":"2439","DOI":"10.1021\/ci700119r","article-title":"Screening of Matrix Metalloproteinases Available from the Protein Data Bank: Insights into Biological Functions, Domain Organization, and Zinc Binding Groups","volume":"47","author":"Nicolotti","year":"2007","journal-title":"J Chem Inf Model"},{"key":"10.1016\/j.bmcl.2022.129014_h0015","doi-asserted-by":"crossref","first-page":"2686","DOI":"10.1038\/jid.2009.130","article-title":"Stromal expression of MMP-13 Is required for melanoma invasion and metastasis","volume":"129","author":"Zigrino","year":"2009","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.bmcl.2022.129014_h0020","doi-asserted-by":"crossref","first-page":"34271","DOI":"10.1074\/jbc.M111.222513","article-title":"Microarray and proteomic analysis of breast cancer cell and osteoblast co-cultures: role of osteoblast matrix metalloproteinase (MMP)-13 in bone metastasis","volume":"286","author":"Morrison","year":"2011","journal-title":"J Biol Chem"},{"key":"10.1016\/j.bmcl.2022.129014_b0015","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1038\/nri1418","article-title":"Matrix metalloproteinases as modulators of inflammation and innate immunity","volume":"4","author":"Parks","year":"2004","journal-title":"Nat Rev Immunol"},{"key":"10.1016\/j.bmcl.2022.129014_h0030","doi-asserted-by":"crossref","first-page":"1318","DOI":"10.1038\/sj.bjc.6600858","article-title":"Role of RANKL-induced osteoclast formation and MMP-dependent matrix degradation in bone destruction by breast cancer metastasis","volume":"88","author":"Ohshiba","year":"2003","journal-title":"Br J Cancer"},{"key":"10.1016\/j.bmcl.2022.129014_h0035","doi-asserted-by":"crossref","first-page":"47","DOI":"10.2174\/138920108783497659","article-title":"Joint diseases and matrix metalloproteinases: A role for MMP-13","volume":"9","author":"Hironari","year":"2008","journal-title":"Curr Pharm Biotechno"},{"key":"10.1016\/j.bmcl.2022.129014_h0040","doi-asserted-by":"crossref","first-page":"R105","DOI":"10.1186\/bcr3047","article-title":"MMP-13 stimulates osteoclast differentiation and activation in tumour breast bone metastases","volume":"13","author":"Pivetta","year":"2011","journal-title":"Breast Cancer Res"},{"key":"10.1016\/j.bmcl.2022.129014_h0045","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0029615","article-title":"An MMP13-selective inhibitor delays primary tumor growth and the onset of tumor-associated osteolytic lesions in experimental models of breast cancer","volume":"7","author":"Shah","year":"2012","journal-title":"PLoS ONE"},{"key":"10.1016\/j.bmcl.2022.129014_h0050","doi-asserted-by":"crossref","first-page":"2415","DOI":"10.1158\/0008-5472.CAN-20-2705","article-title":"Host-derived matrix metalloproteinase-13 activity promotes multiple myeloma-induced osteolysis and reduces overall survival","volume":"81","author":"Lo","year":"2021","journal-title":"Cancer Res"},{"key":"10.1016\/j.bmcl.2022.129014_h0055","doi-asserted-by":"crossref","first-page":"2648","DOI":"10.1002\/art.10531","article-title":"Relative messenger RNA expression profiling of collagenases and aggrecanases in human articular chondrocytes in vivo and in vitro","volume":"46","author":"Bau","year":"2002","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.bmcl.2022.129014_h0060","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1172\/JCI10564","article-title":"Postnatal expression in hyaline cartilage of constitutively active human collagenase-3 (MMP-13) induces osteoarthritis in mice","volume":"107","author":"Neuhold","year":"2001","journal-title":"J Clin Invest"},{"key":"10.1016\/j.bmcl.2022.129014_b0025","doi-asserted-by":"crossref","first-page":"1157","DOI":"10.1002\/cmdc.201700349","article-title":"Recent research advances in selective matrix metalloproteinase-13 inhibitors as anti-osteoarthritis agents","volume":"12","author":"Xie","year":"2017","journal-title":"ChemMedChem"},{"key":"10.1016\/j.bmcl.2022.129014_b0030","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1002\/stem.170237","article-title":"New drugs on the horizon: matrix metalloproteinase inhibitors","volume":"17","author":"Rothenberg","year":"1999","journal-title":"Stem Cells"},{"key":"10.1016\/j.bmcl.2022.129014_b0035","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1002\/1529-0131(200201)46:1<13::AID-ART497>3.0.CO;2-S","article-title":"Matrix metalloproteinases as therapeutic targets in arthritic diseases: Bull's-eye or missing the mark?","volume":"46","author":"Mengshol","year":"2002","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.bmcl.2022.129014_b0040","doi-asserted-by":"crossref","first-page":"949","DOI":"10.2165\/11318390-000000000-00000","article-title":"Matrix metalloproteinase inhibitors","volume":"70","author":"Dorm\u00e1n","year":"2010","journal-title":"Drugs"},{"key":"10.1016\/j.bmcl.2022.129014_h0085","doi-asserted-by":"crossref","first-page":"608","DOI":"10.1021\/acs.jmedchem.6b01007","article-title":"Discovery of novel, highly potent, and selective matrix metalloproteinase (MMP)-13 inhibitors with a 1,2,4-triazol-3-yl moiety as a zinc binding group using a structure-based design approach","volume":"60","author":"Nara","year":"2017","journal-title":"J Med Chem"},{"key":"10.1016\/j.bmcl.2022.129014_h0090","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1021\/jm201152u","article-title":"Discovery and evaluation of a non-Zn chelating, selective matrix metalloproteinase 13 (MMP-13) inhibitor for potential intra-articular treatment of osteoarthritis","volume":"55","author":"Gege","year":"2011","journal-title":"J Med Chem"},{"key":"10.1016\/j.bmcl.2022.129014_h0095","doi-asserted-by":"crossref","first-page":"27781","DOI":"10.1074\/jbc.M703286200","article-title":"Discovery and characterization of a novel inhibitor of matrix metalloprotease-13 that reduces cartilage damage in vivo without joint fibroplasia side effects","volume":"282","author":"Johnson","year":"2007","journal-title":"J Biol Chem"},{"key":"10.1016\/j.bmcl.2022.129014_b0050","doi-asserted-by":"crossref","first-page":"5816","DOI":"10.1021\/acs.jmedchem.7b00514","article-title":"Structure-based design and synthesis of potent and selective matrix metalloproteinase 13 inhibitors","volume":"60","author":"Choi","year":"2017","journal-title":"J Med Chem"},{"key":"10.1016\/j.bmcl.2022.129014_h0105","doi-asserted-by":"crossref","first-page":"990","DOI":"10.1016\/j.bmc.2008.03.004","article-title":"High throughput screening of potentially selective MMP-13 exosite inhibitors utilizing a triple-helical FRET substrate","volume":"17","author":"Lauer-Fields","year":"2009","journal-title":"Bioorg Med Chem"},{"key":"10.1016\/j.bmcl.2022.129014_h0110","doi-asserted-by":"crossref","first-page":"7180","DOI":"10.1016\/j.bmcl.2011.09.077","article-title":"Identification of novel, exosite-binding matrix metalloproteinase-13 inhibitor scaffolds","volume":"21","author":"Roth","year":"2011","journal-title":"Bioorg Med Chem Lett"},{"key":"10.1016\/j.bmcl.2022.129014_h0115","doi-asserted-by":"crossref","first-page":"9598","DOI":"10.1021\/jm501284e","article-title":"Characterization of selective exosite-binding inhibitors of matrix metalloproteinase 13 that prevent articular cartilage degradation in vitro","volume":"57","author":"Spicer","year":"2014","journal-title":"J Med Chem"},{"key":"10.1016\/j.bmcl.2022.129014_h0120","doi-asserted-by":"crossref","first-page":"5487","DOI":"10.1016\/j.bmc.2014.07.025","article-title":"Thieno[2,3-d]pyrimidine-2-carboxamides bearing a carboxybenzene group at 5-position: Highly potent, selective, and orally available MMP-13 inhibitors interacting with the S1'' binding site","volume":"22","author":"Nara","year":"2014","journal-title":"Bioorg Med Chem"},{"key":"10.1016\/j.bmcl.2022.129014_h0125","doi-asserted-by":"crossref","first-page":"6149","DOI":"10.1016\/j.bmc.2016.09.009","article-title":"Design, synthesis, and biological activity of novel, potent, and highly selective fused pyrimidine-2-carboxamide-4-one-based matrix metalloproteinase (MMP)-13 zinc-binding inhibitors","volume":"24","author":"Nara","year":"2016","journal-title":"Bioorg Med Chem"},{"key":"10.1016\/j.bmcl.2022.129014_b0065","series-title":"Drug-like properties: concepts, structure, design and methods: from ADME to toxicity optimization","author":"Kerns","year":"2008"},{"key":"10.1016\/j.bmcl.2022.129014_h0135","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1021\/acs.jmedchem.5b01434","volume":"59","author":"Ruminski","year":"2016","journal-title":"J Med Chem"},{"key":"10.1016\/j.bmcl.2022.129014_h0140","doi-asserted-by":"crossref","first-page":"2292","DOI":"10.1021\/acs.chemrestox.5b00315","article-title":"Toxicity of carboxylic acid-containing drugs: the role of acyl migration and coa conjugation investigated","volume":"28","author":"Lassila","year":"2015","journal-title":"Chem Res Toxicol"},{"key":"10.1016\/j.bmcl.2022.129014_h0145","doi-asserted-by":"crossref","first-page":"1062","DOI":"10.1039\/c2md20111a","article-title":"The developability of heteroaromatic and heteroaliphatic rings \u2013 do some have a better pedigree as potential drug molecules than others?","volume":"3","author":"Ritchie","year":"2012","journal-title":"MedChemComm"},{"key":"10.1016\/j.bmcl.2022.129014_h0150","doi-asserted-by":"crossref","first-page":"6002","DOI":"10.1021\/jm300343m","article-title":"Mitigating heterocycle metabolism in drug discovery","volume":"55","author":"St. Jean","year":"2012","journal-title":"J Med Chem"},{"key":"10.1016\/j.bmcl.2022.129014_b0080","doi-asserted-by":"crossref","DOI":"10.1039\/D0MD00370K","article-title":"C., Put a ring on it: application of small aliphatic rings in medicinal chemistry","author":"Bauer","year":"2021","journal-title":"RSC Med Chem"},{"key":"10.1016\/j.bmcl.2022.129014_b0085","doi-asserted-by":"crossref","first-page":"3227","DOI":"10.1021\/jm9018788","article-title":"Oxetanes in Drug Discovery: Structural and Synthetic Insights","volume":"53","author":"Wuitschik","year":"2010","journal-title":"J Med Chem"},{"key":"10.1016\/j.bmcl.2022.129014_b0090","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/j.tox.2009.01.006","article-title":"Assessment of the renal toxicity of novel anti-inflammatory compounds using cynomolgus monkey and human kidney cells","volume":"258","author":"Cai","year":"2009","journal-title":"Toxicology"},{"key":"10.1016\/j.bmcl.2022.129014_h0170","doi-asserted-by":"crossref","first-page":"4984","DOI":"10.1016\/j.bmc.2018.08.020","article-title":"Development of matrix metalloproteinase-13 inhibitors \u2013 A structure-activity\/structure-property relationship study","volume":"26","author":"Fuerst","year":"2018","journal-title":"Bioorg Med Chem"},{"key":"10.1016\/j.bmcl.2022.129014_h0175","doi-asserted-by":"crossref","first-page":"1133","DOI":"10.1002\/cmdc.202000911","article-title":"Matrix metalloproteinase 13 inhibitors for modulation of osteoclastogenesis: enhancement of solubility and stability","volume":"16","author":"Knapinska","year":"2021","journal-title":"ChemMedChem"},{"key":"10.1016\/j.bmcl.2022.129014_b0100","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1007\/s00011-009-0112-9","article-title":"Novel selective MMP-13 inhibitors reduce collagen degradation in bovine articular and human osteoarthritis cartilage explants","volume":"59","author":"Piecha","year":"2010","journal-title":"Inflamm Res"},{"key":"10.1016\/j.bmcl.2022.129014_h0185","doi-asserted-by":"crossref","first-page":"11201","DOI":"10.1074\/jbc.M111021200","article-title":"Design, synthesis, and characterization of potent, slow-binding inhibitors that are selective for gelatinases","volume":"277","author":"Bernardo","year":"2002","journal-title":"J Biol Chem"},{"key":"10.1016\/j.bmcl.2022.129014_h0190","doi-asserted-by":"crossref","first-page":"812","DOI":"10.1002\/cmdc.200700290","article-title":"Zinc-binding groups modulate selective inhibition of MMPs","volume":"3","author":"Agrawal","year":"2008","journal-title":"ChemMedChem"},{"key":"10.1016\/j.bmcl.2022.129014_h0195","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1016\/j.ejmech.2012.09.036","article-title":"Design, synthesis and biological evaluation of 5-hydroxy, 5-substituted-pyrimidine-2,4,6-triones as potent inhibitors of gelatinases MMP-2 and MMP-9","volume":"58","author":"Nicolotti","year":"2012","journal-title":"Eur J Med Chem"}],"container-title":["Bioorganic &amp; Medicinal Chemistry Letters"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0960894X22004905?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0960894X22004905?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,18]],"date-time":"2025-10-18T07:47:07Z","timestamp":1760773627000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0960894X22004905"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,11]]},"references-count":39,"alternative-id":["S0960894X22004905"],"URL":"https:\/\/doi.org\/10.1016\/j.bmcl.2022.129014","relation":{},"ISSN":["0960-894X"],"issn-type":[{"value":"0960-894X","type":"print"}],"subject":[],"published":{"date-parts":[[2022,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Development of a putative Zn2+-chelating but highly selective MMP-13 inhibitor","name":"articletitle","label":"Article Title"},{"value":"Bioorganic & Medicinal Chemistry Letters","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bmcl.2022.129014","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"129014"}}